Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,928,616
New position
Shares Held
136,541
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in AZN
reported options exposure · as of Mar 31, 2026CallValue
$229,386,582
CallShares
1,163,100
PutValue
$245,972,784
PutShares
1,247,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,324,749,837 across 17 Drug Manufacturers - General names. AZN ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
11,106,111 | $408,149,579 | |
| 2 | JNJ |
Johnson & Johnson
|
844,082 | $206,327,404 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,032,658 | $143,921,545 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,033,222 | $124,286,274 | |
| 5 | AMGN |
Amgen Inc
|
317,913 | $111,857,689 | |
| 6 | ABBV |
AbbVie Inc.
|
431,015 | $93,741,451 | |
| 7 | LLY |
ELI LILLY & Co
|
78,552 | $72,249,773 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
600,889 | $36,443,917 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $229,386,582 | 1,163,100 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $26,928,616 | 136,541 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $245,972,784 | 1,247,200 | Put | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||